{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:19:59Z","timestamp":1783073999898,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12190-2","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:50:07Z","timestamp":1783072207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective modulation of IL-6\/JAK\/STAT-related signaling under redox-shift conditions by luteolin"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-2937","authenticated-orcid":false,"given":"Ay\u015fe Ko\u00e7ak","family":"Sezgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-6377","authenticated-orcid":false,"given":"Meliha Koldemir","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-453X","authenticated-orcid":false,"given":"Elif","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-0208","authenticated-orcid":false,"given":"G\u00fcll\u00fc","family":"Kaymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"12190_CR1","doi-asserted-by":"publisher","first-page":"100796","DOI":"10.1016\/j.drup.2021.100796","volume":"59","author":"R Nussinov","year":"2021","unstructured":"Nussinov R, Tsai CJ, Jang H (2021) Anticancer drug resistance: an update and perspective. Drug Resist Updat 59:100796","journal-title":"Drug Resist Updat"},{"key":"12190_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0031-9422(00)00235-1","volume":"55","author":"JB Harborne","year":"2000","unstructured":"Harborne JB, Williams CA (2000) Advances in flavonoid research since 1992. Phytochemistry 55:481\u2013504","journal-title":"Phytochemistry"},{"key":"12190_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1207\/s15327914nc5001_1","volume":"50","author":"ML Neuhouser","year":"2004","unstructured":"Neuhouser ML (2004) Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50:1\u20137","journal-title":"Nutr Cancer"},{"key":"12190_CR4","doi-asserted-by":"crossref","unstructured":"Miean KH, Mohamed S Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49:3106\u20133112","DOI":"10.1021\/jf000892m"},{"issue":"12","key":"12190_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1021\/np070351s","volume":"70","author":"T Mencherini","year":"2007","unstructured":"Mencherini T, Picerno P, Scesa C, Aquino R (2007) Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis. J Nat Prod 70(12):1889\u20131894","journal-title":"J Nat Prod"},{"key":"12190_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/0891-5849(95)02227-9","volume":"20","author":"CA Rice-Evans","year":"1996","unstructured":"Rice-Evans CA, Miller NJ, Paganga G (1996) Structure anti-oxidant activity relationships of flavonoids and phenolic acids. Free Rad Biol Med 20:933\u2013956","journal-title":"Free Rad Biol Med"},{"key":"12190_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/1071576021000016463","volume":"36","author":"L Mira","year":"2002","unstructured":"Mira L, Fernandez MT, Santos M, Rocha R, Florencio MH, Jennings KR (2002) Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Rad Res 36:1199\u20131208","journal-title":"Free Rad Res"},{"issue":"1","key":"12190_CR8","first-page":"31","volume":"9","author":"LN Miguel","year":"2009","unstructured":"Miguel LN (2009) Distrubition and biological activities of luteolin. Med Chemistrty 9(1):31\u201359","journal-title":"Med Chemistrty"},{"key":"12190_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/B:MCBI.0000044364.73144.fe","volume":"265","author":"C Hu","year":"2004","unstructured":"Hu C, Kitts DD (2004) Luteolin and Luteolin-7-O-glucoside fron dandelion flower supress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem 265:107\u2013113","journal-title":"Mol Cell Biochem"},{"key":"12190_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1089\/jmf.2007.591","volume":"11","author":"BM Choi","year":"2008","unstructured":"Choi BM, Lim DW, Lee JA, Gao SS, Kwon DY (2008) KimBR. Luteolin suppresses Cisplatininduced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression. J Med Food 11:230\u2013236","journal-title":"J Med Food"},{"key":"12190_CR11","doi-asserted-by":"publisher","first-page":"106552","DOI":"10.1016\/j.phrs.2022.106552","volume":"187","author":"Robert","year":"2023","unstructured":"Robert, Roskoski (2023) Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update. Pharmacol Res 187:106552","journal-title":"Pharmacol Res"},{"issue":"7","key":"12190_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.acthis.2011.11.010","volume":"114","author":"ET Uluer","year":"2012","unstructured":"Uluer ET, Aydemir I, Inan S, Ozbilgin K, Vatansever HS (2012) Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK\/STAT pathway. Acta Histochem 114(7):641\u2013646","journal-title":"Acta Histochem"},{"key":"12190_CR13","doi-asserted-by":"crossref","unstructured":"Xing Z, Wang, Xin, Liu, Jiaqi, Liu, Gang, Zhang, Menglu F (2021) Kexin, Wang, Xiang, Effect of MiR-210 on the Chemosensitivity of Breast Cancer by Regulating JAK-STAT Signaling Pathway, BioMed Research International, 7703159, 8: 2021","DOI":"10.1155\/2021\/7703159"},{"issue":"1","key":"12190_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11033-023-09131-8","volume":"51","author":"S Rajabi","year":"2024","unstructured":"Rajabi S, Tahmasvand Z, Maresca M, Hamzeloo-Moghadam M (2024) Gaillardin inhibits autophagy and induces apoptosis in MCF-7 breast cancer cells by regulating JAK\/STAT pathway. Mol Biol Rep 51(1):158","journal-title":"Mol Biol Rep"},{"issue":"3","key":"12190_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/ibd\/izz266","volume":"26","author":"A Sayoc-Becerra","year":"2020","unstructured":"Sayoc-Becerra A, Krishnan M, Fan S, Jimenez J, Hernandez R, Gibson K, Preciado R, Butt G, McCole DF (2020) The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction. Inflamm Bowel Dis 26(3):407\u2013422","journal-title":"Inflamm Bowel Dis"},{"key":"12190_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.molimm.2020.10.007","volume":"128","author":"Y Yue","year":"2020","unstructured":"Yue Y, Zhang Q, Wu S, Wang S, Cui C, Yu M, Sun Z (2020) Identification of key genes involved in JAK\/STAT pathway in colorectal cancer. Mol Immunol 128:287\u2013297","journal-title":"Mol Immunol"},{"key":"12190_CR17","doi-asserted-by":"crossref","unstructured":"Zhang M, Lai J, Wu Q, Lai J, Su J, Zhu B, Li Y (20231) Naringenin Induces HepG2 Cell Apoptosis via ROS-Mediated JAK-2\/STAT-3 Signaling Pathways. Molecules 28(11):4506","DOI":"10.3390\/molecules28114506"},{"key":"12190_CR18","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1002\/jcp.29593","volume":"235","author":"A Hosseini","year":"2020","unstructured":"Hosseini A, Gharibi T, Marofi et al (2020) Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases. J Cell Physiol 235:5903\u20135924","journal-title":"J Cell Physiol"},{"issue":"1","key":"12190_CR19","doi-asserted-by":"publisher","first-page":"e002012","DOI":"10.1136\/rmdopen-2021-002012","volume":"8","author":"R Fleischmann","year":"2022","unstructured":"Fleischmann R, Mysler E, Bessette L et al (2022) Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study. RMD Open 8(1):e002012","journal-title":"RMD Open"},{"key":"12190_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bcpt.13944","volume":"133","author":"P Tveden-Nyborg","year":"2023","unstructured":"Tveden-Nyborg P, Bergmann TK, Jessen N et al (2023) BCPT 2023 policy for experimental and clinical studies. Basic Clin Pharmacol Toxicol 133:391\u2013396","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"12190_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277\u2013285","journal-title":"Clin Biochem"},{"key":"12190_CR22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103\u20131111","journal-title":"Clin Biochem"},{"key":"12190_CR23","doi-asserted-by":"crossref","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev.; 2014: 360438","DOI":"10.1155\/2014\/360438"},{"key":"12190_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"key":"12190_CR25","first-page":"882","volume":"61","author":"E Beutler","year":"1963","unstructured":"Beutler E (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882\u2013888","journal-title":"J Lab Clin Med"},{"issue":"6","key":"12190_CR26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3(6):1101\u20131108","journal-title":"Nat Protoc"},{"issue":"5","key":"12190_CR27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5455\/annalsmedres.2023.02.051","volume":"30","author":"A Kocak","year":"2023","unstructured":"Kocak A, Yucebas I, Altin E, Upadacitinib (2023) PD29 have anti-inflammatory and antioxidant effects on MCF-7 cells. Annals Med Res 30(5):590\u2013594","journal-title":"Annals Med Res"},{"issue":"3","key":"12190_CR28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/vaccines11030554","volume":"11","author":"M \u00c7etinkaya","year":"2023","unstructured":"\u00c7etinkaya M, Baran Y (2023) Therapeutic Potential of Luteolin on Cancer. Vaccines (Basel) 11(3):554","journal-title":"Vaccines (Basel)"},{"issue":"10302","key":"12190_CR29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","volume":"28","author":"DP McLornan","year":"2021","unstructured":"McLornan DP, Pope JE, Gotlib J et al (2021) Current and future status of JAK inhibitors. Lancet 28(10302):803\u2013816","journal-title":"Lancet"},{"key":"12190_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","volume":"10","author":"R Catlett-Falcone","year":"1999","unstructured":"Catlett-Falcone R et al (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105\u2013115","journal-title":"Immunity"},{"issue":"25","key":"12190_CR31","first-page":"5137","volume":"28","author":"F Shao","year":"2021","unstructured":"Shao F, Pang X, Baeg GH (2021) Targeting the JAK\/STAT signaling pathway for breast cancer. Curr Med 28(25):5137\u20135151","journal-title":"Curr Med"},{"key":"12190_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/or.2012.2158","volume":"29","author":"YW Jeon","year":"2013","unstructured":"Jeon YW, Suh YJ (2013) Synergistic Apoptotic Effect of Celecoxib and Luteolin on Breast Cancer. Cells Oncol Rep 29:819\u2013825","journal-title":"Cells Oncol Rep"},{"key":"12190_CR33","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1007\/s13277-015-3322-5","volume":"36","author":"YW Jeon","year":"2015","unstructured":"Jeon YW, Ahn YE, Chung WS et al (2015) Synergistic Effect between Celecoxib and Luteolin Is Dependent on Estrogen Receptor in Human Breast Cancer Cells. Tumor Biol 36:6349\u20136359","journal-title":"Tumor Biol"},{"key":"12190_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cbi.2014.02.002","volume":"213","author":"MY Yang","year":"2014","unstructured":"Yang MY, Wang CJ, Chen NF et al (2014) Luteolin Enhances Paclitaxel-Induced Apoptosis in Human Breast Cancer MDA-MB-231 Cells by Blocking STAT3. Chem Biol Interact 213:60\u201368","journal-title":"Chem Biol Interact"},{"key":"12190_CR35","doi-asserted-by":"publisher","first-page":"107059","DOI":"10.1016\/j.phrs.2024.107059","volume":"200","author":"R Roskoski Jr","year":"2024","unstructured":"Roskoski R Jr. (2024) Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update. Pharmacol Res 200:107059. https:\/\/doi.org\/10.1016\/j.phrs.2024.107059","journal-title":"Pharmacol Res"},{"key":"12190_CR40","doi-asserted-by":"crossref","unstructured":"Ko\u00e7ak A, G\u00fcnek E, Ayd\u0131n E, G\u00fcnd\u00fcz MK, Kaymak G (2025) Therapeutic Effects of Finerenone and Exenatide on Diabetes-Induced Heart Failure: A Combined Approach Targeting Inflammation and Oxidative Stress. Eur J Pharmacol, 177826","DOI":"10.1016\/j.ejphar.2025.177826"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12190-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:50:22Z","timestamp":1783072222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12190-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12190"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12190-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1088"}}